Effect of Eight Weeks of High-Intensity Interval Training (HIIT) on Serum Asprosin Levels and Body Composition in Overweight and Obese Men
Keywords:
High-intensity Interval Training, Asprosin, Body Composition, Obese MenAbstract
Objective: This study aimed to investigate the impact of 8 weeks of high-intensity interval training (HIIT) on serum Asprosin levels and body composition in overweight and obese men.
Methods and Materials: A total of 36 overweight and obese men with a body mass index (BMI) of 25 to 34.9 aged between 30 and 35 years, were voluntarily selected and randomly assigned to either the HIIT group or a control group in a semi-experimental, pre-post study design. The HIIT intervention lasted for eight weeks, consisting of three sessions per week. Asprosin was measured using ELISA, while body composition was assessed via InBody 230 analysis. Statistical comparisons were performed using ANCOVA with significance set at α < 0.05.
Findings: Following the intervention, the HIIT group exhibited significant reductions in serum asprosin levels (F = 134.06, p < 0.01), body fat percentage (F = 186.79, p < 0.01), BMI (F = 25.36, p < 0.01), lean body mass (F = 9.88, p = 0.004), and waist-to-hip ratio (F = 9.88, p < 0.01).
Conclusion: These findings support the role of HIIT as an effective non-pharmacological strategy for reducing serum Asprosin levels and improving body composition in overweight and obese populations.
Downloads
References
1. Shafiee A, Nakhaee Z, Bahri RA, Amini MJ, Salehi A, Jafarabady K, et al. Global Prevalence Of Obesity And Overweight Among Medical Students: A Systematic Review And Meta-Analysis. BMC public health. 2024;24(1):1673. [PMID: 38915047] [PMCID: PMC11194880]
2. Lobstein T, Jackson-Leach R, Powis, Jaynaide, Brinsden H, Gray M. World Obesity Atlas 2023 London: World Obesity Federation; 2023 [Available from: https://data.worldobesity.org/publications/?cat=19
3. Lin X, Li H. Obesity: Epidemiology, Pathophysiology, And Therapeutics. Frontiers in endocrinology. 2021;12:706978. [PMID: 34552557] [PMCID: PMC8450866]
4. Chooi YC, Ding C, Magkos F. The Epidemiology Of Obesity. Metabolism. 2019;92:6-10. [PMID: 30253139]
5. Karampela I, Christodoulatos GS, Dalamaga M. The Role Of Adipose Tissue And Adipokines In Sepsis: Inflammatory And Metabolic Considerations, And The Obesity Paradox. Current obesity reports. 2019;8:434-57. [PMID: 31637623]
6. Zorena K, Jachimowicz-Duda O, Ślęzak D, Robakowska M, Mrugacz M. Adipokines And Obesity. Potential Link To Metabolic Disorders And Chronic Complications. International journal of molecular sciences. 2020;21(10):3570. [PMID: 32443588] [PMCID: PMC7278967]
7. Ceylan HIB, Saygın Ö. An Investigation Of The Relationship Between New Fasting Hormone Asprosin, Obesity And Acute–Chronic Exercise: Current Systematic Review. Archives of Physiology and Biochemistry. 2021;127(4):373-84. [PMID: 32427509]
8. Yuan M, Li W, Zhu Y, Yu B, Wu J. Asprosin: A Novel Player In Metabolic Diseases. Frontiers in endocrinology. 2020;11:64. [PMID: 32153505] [PMCID: PMC7045041]
9. Li E, Shan H, Chen L, Long A, Zhang Y, Liu Y, et al. Olfr734 Mediates Glucose Metabolism As A Receptor Of Asprosin. Cell metabolism. 2019;30(2):319-28. e8. [PMID: 31230984] [PMCID: PMC8102062]
10. Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, et al. Asprosin, A Fasting-Induced Glucogenic Protein Hormone. Cell. 2016;165(3):566-79. [PMID: 27087445] [PMCID: PMC4852710]
11. Duerrschmid C, He Y, Wang C, Li C, Bournat JC, Romere C, et al. Asprosin Is A Centrally Acting Orexigenic Hormone. Nature medicine. 2017;23(12):1444-53. [PMID: 29106398] [PMCID: PMC5720914]
12. Mazur-Bialy AI. Asprosin—A Fasting-Induced, Glucogenic, And Orexigenic Adipokine As A New Promising Player. Will It Be A New Factor In The Treatment Of Obesity, Diabetes, OR Infertility? A Review Of The Literature. Nutrients. 2021;13(2):620. [PMID: 33673009] [PMCID: PMC7918151]
13. Ugur K, Aydin S. Saliva And Blood Asprosin Hormone Concentration Associated With Obesity. International journal of endocrinology. 2019;2019(1):2521096. [PMID: 31049060] [PMCID: PMC6458951]
14. Dolataabadi P, Amirsasan R, Vakili J. The Effect Of High-Intensity Circuit Training On Serum Asprosin, Lipid Profile And Some Fitness Factors In Overweight And Obese Women. Journal of Applied Health Studies in Sport Physiology. 2023;10(1):14-26.
15. Mabhut Moghadam T, Fathi M, Attarzadeh Hosseini SR, Rashid Lamir A, Mosaferi Ziaaldini M. Effect Of High Intensity Aerobic Exercise Training And Arginine Supplementation On Hormonal Changes In Leptin And Agouti-Related Protein (Agrp) In Obese Adolescent Boys. Journal of Sport Biosciencesis 2018;10(1):133-48.
16. Martins C, Morgan L, Truby H. A Review Of The Effects Of Exercise On Appetite Regulation: An Obesity Perspective. International journal of obesity. 2008;32(9):1337-47. [PMID: 18607378]
17. Festiawan R, Hoi LB, Siswantoyo N, Kusuma IJ, Heza FN, Wahono B, et al. High-Intensity Interval Training, Fartlek Training & Oregon Circuit Training: What Are The Best Exercises To Increase Vo2 Max. Annals of Tropical Medicine & Public Health. 2021;24(03):0-10.
18. Guiraud T, Nigam A, Gremeaux V, Meyer P, Juneau M, Bosquet L. High-Intensity Interval Training In Cardiac Rehabilitation. Sports medicine. 2012;42:587-605. [PMID: 22694349]
19. Dolataabadi P, Amirsasan R, Vakili J. The Effect Of High-Intensity Interval Training On Serum Asprosin And Lipid Profile Of Overweight And Obese Women. Journal of Practical Studies of Biosciences in Sport. 2023;11(27):22-33.
20. Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, et al. The Effects Of Free-Living Interval-Walking Training On Glycemic Control, Body Composition, And Physical Fitness In Type 2 Diabetic Patients: A Randomized, Controlled Trial. Diabetes care. 2013;36(2):228-36. [PMID: 23002086] [PMCID: PMC3554285]
21. Gerosa-Neto J, Antunes BM, Campos EZ, Rodrigues J, Ferrari GD, Neto JCR, et al. Impact Of Long-Term High-Intensity Interval And Moderate-Intensity Continuous Training On Subclinical Inflammation In Overweight/Obese Adults. Journal of exercise rehabilitation. 2016;12(6):575. [PMID: 28119880] [PMCID: PMC5227320]
22. Adams OP. The Impact Of Brief High-Intensity Exercise On Blood Glucose Levels. Diabetes, metabolic syndrome and obesity: targets and therapy. 2013:113-22. [PMID: 23467903] [PMCID: PMC3587394]
23. Williams N. The Borg Rating Of Perceived Exertion (Rpe) Scale. Occupational Medicine. 2017;67(5):404–5.
24. Alahmadi MA. High-Intensity Interval Training And Obesity. J Nov Physiother. 2014;4(3):211.
25. Dave P. Combating The Obesity Crisis: The Role Of Community Pharmacists In Addressing The Rising Obesity Numbers. Journal of Drug Delivery and Therapeutics. 2024;14(6):184-90.
26. Delfan M, Saeidi A, Supriya R, Escobar KA, Laher I, Heinrich KM, et al. Enhancing Cardiometabolic Health: Unveiling The Synergistic Effects Of High-Intensity Interval Training With Spirulina Supplementation On Selected Adipokines, Insulin Resistance, And Anthropometric Indices In Obese Males. Nutrition & Metabolism. 2024;21(1):11. [PMID: 38454429] [PMCID: PMC10921712]
27. Liu L, Liu Y, Huang M, Zhang M, Zhu C, Chen X, et al. The Effects Of Asprosin On Exercise-Intervention In Metabolic Diseases. Frontiers in physiology. 2022;13:907358. [PMID: 35899030] [PMCID: PMC9311488]
28. Greenhill C. Asprosin—New Hormone Involved In Hepatic Glucose Release. Nature Reviews Endocrinology. 2016;12(6):312-. [PMID: 27125501]
29. Donma MM, Donma O. Asprosin: Possible Target In Connection With Ghrelin And Cytokine Network Expression In The Post-Burn Treatment. Medical hypotheses. 2018;118:163-8. [PMID: 30037606]
30. Kantorowicz M, Szymura J, Szygula Z, Kusmierczyk J, Maciejczyk M, Wiecek M. Nordic Walking At Maximal Fat Oxidation Intensity Decreases Circulating Asprosin And Visceral Obesity In Women With Metabolic Disorders. Frontiers in Physiology. 2021;12:726783. [PMID: 34539448] [PMCID: PMC8446531]
31. Gonzalez-Gil AM, Elizondo-Montemayor L. The Role Of Exercise In The Interplay Between Myokines, Hepatokines, Osteokines, Adipokines, And Modulation Of Inflammation For Energy Substrate Redistribution And Fat Mass Loss: A Review. Nutrients. 2020;12(6):1899. [PMID: 32604889] [PMCID: PMC7353393]
32. KO JR, Seo DY, Kim TN, Park SH, Kwak H-B, KO KS, et al. Aerobic Exercise Training Decreases Hepatic Asprosin In Diabetic Rats. Journal of clinical medicine. 2019;8(5):666. [PMID: 31083617] [PMCID: PMC6572469]
33. Jahangiri M, Shahrbanian S, Hackney AC. Changes In The Level Of Asprosin As A Novel Adipocytokine After Different Types Of Resistance Training. Journal of chemical health risks. 2021;11(Spec Iss):179.
34. Schumann U, Qiu S, Enders K, Bosnyák E, Laszlo R, Machus K, et al. Asprosin, A Newly Identified Fasting-Induced Hormone Is Not Elevated In Obesity And Is Insensitive To Acute Exercise: 3592 Board# 39 June 3 8: 00 Am-9: 30 Am. Medicine & science in sports & exercise. 2017;49(5S):1023.
35. Wiecek M, Szymura J, Maciejczyk M, Kantorowicz M, Szygula Z. Acute Anaerobic Exercise Affects The Secretion Of Asprosin, Irisin, And Other Cytokines–A Comparison Between Sexes. Frontiers in physiology. 2018;9:1782. [PMID: 30618797] [PMCID: PMC6295572]
36. Westerterp KR. Exercise, Energy Balance And Body Composition. European journal of clinical nutrition. 2018;72(9):1246-50. [PMID: 30185845] [PMCID: PMC6125254]
37. Meex RC, Blaak EE, Van Loon LJ. Lipotoxicity Plays A Key Role In The Development Of Both Insulin Resistance And Muscle Atrophy In Patients With Type 2 Diabetes. Obesity Reviews. 2019;20(9):1205-17. [PMID: 31240819] [PMCID: PMC6852205]
38. Jung UJ, Choi M-S. Obesity And Its Metabolic Complications: The Role Of Adipokines And The Relationship Between Obesity, Inflammation, Insulin Resistance, Dyslipidemia And Nonalcoholic Fatty Liver Disease. International journal of molecular sciences. 2014;15(4):6184-223. [PMID: 24733068] [PMCID: PMC4013623]
